Clinical Trial

Oxytocin on the Neurobiology of Anorexia Nervosa

Study Description

The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa

This study will use a randomized, controlled, double-blind design involving the administration of intranasal oxytocin (INOT) or placebo to adults with anorexia nervosa, restricting subtype and age-matched controls prior to neuroimaging to assess the impact on frontolimbic brain activity in response to socioemotional stimuli as well as eating behavior in a test meal paradigm.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Biological - Intranasal oxytocin

oxytocin is a peptide hormone that influences social affiliation

Additional Information

Official Study Title

Investigating the Impact of Oxytocin on the Neurobiological Underpinnings of Socioemotional Deficits in Anorexia Nervosa

Clinical Trial ID

NCT03414112

ParticipAid ID

ZdP3yb